Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D

References

• Kohli P, Cannon CP. Statins and safety: can we finally be reassured? Lancet 2011;378:1980-1
   PubMed Web of Science ®Google Scholar
• Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010;170:1024-31
   PubMed Web of Science ®Google Scholar
• Nichols GA, Koro CE. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Clin Ther 2007;29:1761-70
   PubMed Web of Science ®Google Scholar
• Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med 2009;150:858-68
   PubMed Web of Science ®Google Scholar
• Rallidis LS, Fountoulaki K, Anastasiou-Nana M. Managing the underestimated risk of statin-associated myopathy. Int J Cardiol 2011: published online 2 August 2011, doi:10.1016/j.ijcard.2011.07.048
   Google Scholar
• Harper CR, Jacobson TA. Evidence-based management of statin myopathy. Curr Atheroscler Rep 2010;12:322-30
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004;80:752-8
   PubMed Web of Science ®Google Scholar
• Erkal MZ, Wilde J, Bilgin Y, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 2006;17:1133-40
   PubMed Web of Science ®Google Scholar
• Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J. 2001;33:19-24
   PubMedGoogle Scholar
• Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28
   PubMed Web of Science ®Google Scholar
• Ahmed W, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis–myalgia in statin-treated patients. Transl Res 2009;153:11-16
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Budhani SB, Masineni SS, et al. Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance. Curr Med Res Opin 2011;27:1683-90
   PubMed Web of Science ®Google Scholar
• Lee P, Greenfield JR, Campbell LV. Vitamin D insufficiency – a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf). 2009;71:154-5
   Google Scholar
• World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 2008. Available from: www.wma.net/en/30publications/10policies/b3/17c.pdf [Last accessed 28 August 2011]
   Google Scholar
• Abd TT, Jacobson TA. Statin-induced myopathy: a review and update. Expert Opin Drug Saf 2011;10:373-87
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-16
   PubMed Web of Science ®Google Scholar
• Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006;92:26-32
   PubMed Web of Science ®Google Scholar
• Bruckert E, Hayem G, Dejager S, et al. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients – the PRIMO study. Cardiovasc Drugs Ther 2005;19:403-14
   PubMed Web of Science ®Google Scholar
• Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003;289:1681-90
   PubMed Web of Science ®Google Scholar
• Piche ME, Lemieux S, Weisnagel SJ, et al. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005;96:92-7
   PubMed Web of Science ®Google Scholar
• Guldiken S, Demir M, Arikan E, et al. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res 2007;119:79-84
   PubMed Web of Science ®Google Scholar
• Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. ATTICA Study. The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA study. Prev Med 2005;40:432-7
   PubMed Web of Science ®Google Scholar
• Ortega E, Garcia JJ, Bote ME, et al. Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. Exerc Immunol Rev 2009;15:42-65
   PubMed Web of Science ®Google Scholar
• Ramel A, Martinez JA, Kiely M, et al. Effects of weight loss and seafood consumption on inflammation parameters in young, overweight and obese European men and women during 8 weeks of energy restriction. Eur J Clin Nutr 2010;64:987-93
   PubMed Web of Science ®Google Scholar
• Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 2008;153(Suppl 1):S200-15
   PubMed Web of Science ®Google Scholar
• Kurnik D, Hochman I, Vesterman-Landes J, et al. Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clin Endocrinol (Oxf). 2012 Jul;77(1):36-41
   Google Scholar
• Gupta A, Thompson PD. The relationship of vitamin D deficiency to statin myopathy. Atherosclerosis 2011;215:23-9
   PubMed Web of Science ®Google Scholar
• Snellman G, Melhus H, Gedeborg R, et al. Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One 2009;4:e7747
   PubMed Web of Science ®Google Scholar